Defining the necessary steps in antibody developmentGain a deep understanding of the antibody development process with this detailed guide. Learn about each critical step from research to market.May 24, 2024
From idea, to molecule, to medicineThe step-by-step evolution of a potential new approach to treating cancer.May 23, 2023
From “magic bullets” to new generation antibodiesWith today's health challenges, medical progress is more important than ever. Therapeutic antibodies are addressing the complexity of targeting diseases with unmet medical need.November 23, 2021
Biotechnology: Bispecific antibodiesWe’re engineering complex molecules that hit more than one target at once to address retinal diseases.November 23, 2021
Biotechnology: CrossMAb technologyWe’re engineering complex molecules that hit more than one target at once to address retinal diseases.November 23, 2021
Ten remarkable facts about making antibody medicinesAntibodies are an important part of our immune system and antibody medicines can help fight diseases. Learn about the complex process needed to make them.November 11, 2021
Our approach to cancer immunotherapyRoche are leading in cancer immunotherapy through innovative research, including immune profiling, with the goal to develop treatment tailored to individuals.November 03, 2021
A breakthrough in fighting blood cancerDiscover how the collaboration between Roche and a small start-up promises to impact cancer.November 03, 2021
Behind the scenes at our experimental manufacturing siteCells never sleep, so we test equipment and processes around the clock to make new medicines faster and safer.November 05, 2020
Learning about the science behind NMOSDUnderstanding neuromyelitis optica spectrum disorder (NMOSD) and the role of interleukin-6 in the inflammation that occurs in people with NMOSDSeptember 06, 2019
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)